What is Allozymes?
Allozymes operates at the intersection of biotechnology and advanced microfluidics, focusing on the discovery and engineering of enzymes. The company's innovative approach enables the creation of sustainable biosolutions applicable to a wide array of industries, including pharmaceuticals, life sciences, food and nutrition, chemicals, bioremediation, and personal care. By offering enzyme engineering services and biosolutions licensing, Allozymes empowers clients to enhance efficiency and reduce their environmental footprint, driving a transition towards greener industrial practices.
How much funding has Allozymes raised?
Allozymes has raised a total of $20M across 2 funding rounds:
Angel/Seed
$5M
Series A
$15M
Angel/Seed (2021): $5M with participation from Entrepreneur First, Xora Innovation, HAX, and TI Platform Management
Series A (2024): $15M led by SOSV, Seventure Partners, and Entrepreneur First
Key Investors in Allozymes
SOSV
SOSV is a multi-stage venture capital investor that provides intellectual and financial capital to accelerate founders big ideas.
Seventure Partners
Seventure Partners is an active partner of innovative companies in the fields of digital technologies and life sciences, investing in health, nutrition, fintech, and sustainable blue economy initiatives.
Entrepreneur First
Entrepreneur First is an international Talent Investor, supporting individuals in building technology companies since 2011.
What's next for Allozymes?
The recent major strategic investment in Allozymes signals a strong confidence in its growth trajectory and its capacity to scale its innovative enzyme technologies. This capital infusion is expected to accelerate the company's research and development efforts, expand its market reach, and further solidify its position as a leader in sustainable biosolutions. Allozymes is poised to leverage this backing to forge new partnerships and deliver impactful, eco-friendly alternatives across diverse industrial sectors.
See full Allozymes company page
